CYTOSORBENTS CORP's ticker is CTSO and the CUSIP is 23283X206. A total of 38 filers reported holding CYTOSORBENTS CORP in Q1 2017. The put-call ratio across all filers is 2.26 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $3,665,156 | -47.6% | 1,949,551 | 0.0% | 0.00% | – |
Q2 2023 | $6,998,888 | +6.1% | 1,949,551 | -0.4% | 0.00% | – |
Q1 2023 | $6,594,510 | +117.4% | 1,956,828 | 0.0% | 0.00% | – |
Q4 2022 | $3,033,084 | +14.0% | 1,956,828 | +0.0% | 0.00% | – |
Q3 2022 | $2,660,000 | -37.9% | 1,955,943 | 0.0% | 0.00% | – |
Q2 2022 | $4,283,000 | -38.8% | 1,955,943 | -10.8% | 0.00% | – |
Q1 2022 | $6,999,000 | -24.4% | 2,193,922 | -0.7% | 0.00% | – |
Q4 2021 | $9,257,000 | -39.1% | 2,209,165 | +18.0% | 0.00% | – |
Q3 2021 | $15,206,000 | -4.7% | 1,872,616 | -11.4% | 0.00% | – |
Q2 2021 | $15,950,000 | -12.6% | 2,112,567 | +0.5% | 0.00% | – |
Q1 2021 | $18,244,000 | +3.0% | 2,101,938 | -5.4% | 0.00% | -100.0% |
Q4 2020 | $17,706,000 | +17.1% | 2,221,606 | +17.2% | 0.00% | 0.0% |
Q3 2020 | $15,123,000 | -4.1% | 1,896,251 | +19.1% | 0.00% | 0.0% |
Q2 2020 | $15,769,000 | +44.7% | 1,592,814 | +12.9% | 0.00% | – |
Q1 2020 | $10,901,000 | +101.6% | 1,410,234 | +0.4% | 0.00% | – |
Q4 2019 | $5,407,000 | -23.7% | 1,404,466 | -0.3% | 0.00% | – |
Q3 2019 | $7,087,000 | -22.1% | 1,408,896 | +2.4% | 0.00% | – |
Q2 2019 | $9,094,000 | -12.2% | 1,375,707 | +0.5% | 0.00% | – |
Q1 2019 | $10,363,000 | -1.5% | 1,369,009 | +5.1% | 0.00% | – |
Q4 2018 | $10,526,000 | -33.6% | 1,302,726 | +6.1% | 0.00% | -100.0% |
Q3 2018 | $15,843,000 | +10.7% | 1,228,116 | -2.2% | 0.00% | 0.0% |
Q2 2018 | $14,316,000 | +103.3% | 1,255,761 | +25.7% | 0.00% | – |
Q1 2018 | $7,041,000 | +27.2% | 998,726 | +17.3% | 0.00% | – |
Q4 2017 | $5,535,000 | +11.6% | 851,576 | +6.5% | 0.00% | – |
Q3 2017 | $4,960,000 | +155.1% | 799,932 | +77.0% | 0.00% | – |
Q2 2017 | $1,944,000 | -23.8% | 452,056 | -20.3% | 0.00% | – |
Q1 2017 | $2,552,000 | -14.2% | 567,116 | +3.9% | 0.00% | – |
Q4 2016 | $2,975,000 | -16.8% | 545,804 | -2.2% | 0.00% | – |
Q3 2016 | $3,574,000 | +46.1% | 558,343 | +3.8% | 0.00% | – |
Q2 2016 | $2,447,000 | +17.3% | 537,707 | +1.0% | 0.00% | – |
Q1 2016 | $2,086,000 | -26.3% | 532,261 | +4.8% | 0.00% | – |
Q4 2015 | $2,830,000 | -98.3% | 508,063 | -90.6% | 0.00% | -100.0% |
Q3 2015 | $161,963,000 | +5424.0% | 5,397,469 | +1030.5% | 0.01% | – |
Q2 2015 | $2,932,000 | -10.5% | 477,437 | +92.3% | 0.00% | – |
Q1 2015 | $3,275,000 | – | 248,277 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Sargent Investment Group, LLC | 249,430 | $2,015,000 | 1.24% |
Manatuck Hill Partners, LLC | 194,100 | $1,568,000 | 0.81% |
Skylands Capital, LLC | 495,850 | $4,006,000 | 0.66% |
EAM Global Investors LLC | 78,027 | $630,000 | 0.34% |
EAM Investors, LLC | 107,531 | $869,000 | 0.24% |
Granahan Investment Management | 278,170 | $2,248,000 | 0.16% |
Wealthcare Advisory Partners LLC | 62,079 | $502,000 | 0.10% |
Avenir Corp | 76,390 | $617,000 | 0.08% |
Crow Point Partners, LLC | 48,576 | $380,000 | 0.07% |
Kalos Management, Inc. | 14,700 | $120,000 | 0.06% |